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Abstract 
 
The purpose of this thesis project is to measure the level of knowledge that university students 
have regarding state and national illicit drug classifications in the United States and associated 
penalties with these classifications, as well as the harms resulting from consuming illicit drugs. 
This particular study, which is to be conducted as a replication study to Higson’s campus-based 
study on the UK drug policy, focuses on a different campus population in regards to the U.S. 
drug policy. Replication studies such as these are beneficial to previous studies because such 
additional research will not only strengthen the findings and correct additional errors, but new 
research may also explore new limitations to the data. Through survey-based research, a 40-
student sample of East Tennessee State University Students (ETSU) will be asked to complete a 
questionnaire testing their knowledge on illicit drug policies and their harms. Such research and 
collection of data is important because based on student feedback, recommendations can be 
made in regards to educating young adults on areas such as illicit drug classifications, sentencing 
penalties, and potential harms.  
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Chapter 1: Literature Review 
The non-medical use of drugs is a world-wide issue, in spite of growing governmental 
and citizen efforts to hinder or stop its use (Babor, 2010, p. 3). Studies from the National Survey 
on Drug Use and Health (2012) revealed that in 2012, 43.6 percent of 18-to 25-year-olds 
reported using an illicit drug in the past month, representing the highest percentages of drug use 
as compared to other age populations. This study reveals that there is a much higher 
concentration of illicit drug use in university-level students in comparison to other age groups.   
The past two decades of American history has witnessed numerous developments 
involving the prevention of drug abuse (Botvin, 2000, p. 39). In 2007, the President of the 
National Center on Addiction and Substance Abuse “called for a major shift in American 
attitudes about substance abuse and addiction” (Manchikanti, 2007, p. 400). However, research 
is mixed with attitudes on whether U.S. drug policy should try to reduce actual drug use or 
should instead strive to decrease the harms that drugs cause to a society (Reuter & Caulkins, 
1995, p. 1059). In an attempt to curb drug use, the first U.S. Drug Court was established in 1989 
and has since spanned to existence in every state. Drug Treatment Courts emerged as an 
acknowledgement that traditional efforts within the criminal justice system were not working to 
reduce illicit drug use (Hora, Schma, & Rosenthal, 1998, p. 448-449). In addition to these Drug 
Treatment Courts, schools have undertaken considerable efforts in the past several years to not 
only detect the underlying influences of drug use, but also to inhibit the use of these drugs 
through the establishment of intervention programs (Dusenbury, Brannigan, Falco, & Hansen, 
2003, p. 237). Most commonly, these programs involve stating the dangers of drug use to 
students and trying to “scare kids into not using drugs” (Botvin, 2000, p. 39). Nevertheless, 
despite best efforts, research has shown that “poor implementation is likely to result in a loss of 
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program effectiveness” (Dusenbury et al., 2003, p. 253). Studies have clearly shown that 
methods such as using scare techniques and teaching on the dangers of drugs has been 
ineffective, and yet numerous schools throughout the U.S. still persist in using such programs 
(Botvin, 2000, p. 39). 
An examination of previous literature on this topic indicates a growing concern over 
substance abuse and the prevalence of drugs in society despite the various policies, programs, 
and efforts from both governmental and private sources alike. Despite the heavy amount of 
literature and programs on the topic of illicit drug penalties and harms, the overall effectiveness 
of these and other preventative measures on drug abuse remain questionable in light of the 
American and worldwide drug epidemic, specifically as seen in the adolescent population (Segal, 
1995; Tolbler, 1986). For these reasons, it becomes more readily apparent why the need for 
researching the actual knowledge and awareness of the drug policy and associated harms in the 
population exists.  
The use of illicit drugs among young people is far from being a minor concern. As 
previously stated, 43.6 percent of 18-to 25-year-olds had a reported illicit drug use in the past 
month, with cannabis being the most commonly-used illicit substance among the population 
(Macleod, et. al, 2004, 1579). This age range of late teens and twenties reflects the highest 
percentage of drug use, as compared to age groups younger and older. Taking into account this 
information, it becomes even highly important to examine whether or not the current strategies 
that lie within some of the most major contributors to voicing the various harms and policies 
regarding illicit drug abuse – particularly those that stem from the political, educational, and 
health arenas – are useful if improvement of these strategies are necessary (Boys, et. al, 2001).  
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In light of these studies, the intent of this research is to question student knowledge on 
the many aspects of illicit drug use—how they are classified under the law, the resultant 
penalties from abusing these drugs, and finally the expected harms that one might expect to arise 
following the abuse of these drugs. It is important that the current illicit drug policies be tested 
for their level of awareness in the population of young people who represent the majority of 
these consumption offenses, thereby judging the actual effectiveness of drug policies within the 
United States. In comparing the students’ responses in these categories, this research will help 
bring to light those factors—whether government-influenced (policies), self-influenced (personal 
harms that may result), or both—that seem to deter students’ decisions with whether or not to 
take illicit drugs.  
Chapter 2: Methodology 
Sampling 
Participants involved in this study were students currently enrolled at East Tennessee 
State University who fell in the age range of 18-25 years old. The reason for such a specific 
choice of age is because studies from the National Survey on Drug Use and Health (2012) 
revealed that “in 2012, the rate of current illicit drug use was higher among young adults aged 18 
to 25 (21.3 percent) than among youths aged 12 to 17 (9.5 percent) and adults aged 26 or older 
(7.0 percent)”. Therefore, remaining within those limits will make the research more comparable 
to other studies. University students under the age of 18 or above the age of 25 were not included 
in this research, as such ages would fall outside the targeted population to be studied.  
Selection of participants was based on non-probability convenience sampling, so that the 
researcher could explore convenient research options through selecting “the most readily 
available respondents, regardless of characteristics, until the required sample size has been 
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achieved” (Tansey, 2007, p. 16). This sampling method was used in surveying entire classrooms 
at a time, so that “a sample of the wider student body” (Tansey, 2007, p. 17) could be better 
achieved in a convenient and profitable timespan. Online surveys were not used due to the 
limited time frame of the research, as such online surveys occasionally yield low participation 
rates and inefficient data collection. For these reasons, a self-completion questionnaire was 
distributed to the students in their regular classroom settings, allowing for ease of data collection 
once the surveys were completed. Participant recruitment was accessed within the East 
Tennessee State University population, through researcher’s access to sufficient student 
classroom populations with the help of willing faculty. Professors of these classes granted the 
researcher fifteen minutes of class time to explain, distribute, and collect the questionnaires from 
students who fell in the age range of 18-25 and who consented to taking the questionnaire.  
Using non-probability convenience sampling, the researcher was able to obtain 40 total 
participants. Of course, it is understood that in research, it is important to have a large 
representative sample size in order to generalize the results of the study back to the entire 
population (Marshall, 1996, p. 522). Due to the limited time frame of the research and 
availability to access entire classrooms at faculty approval, attempts to survey a larger population 
sample would have required a longer period of research than that which was currently allotted. 
Nonetheless, this research objective, which was to survey a small sample of ETSU students in an 
effort to better determine their level of knowledge on the given topic of drugs, was fully 
accomplished using the convenience sampling method. 
Research Design 
This study is a replication study to the research performed by Carol Higson, who 
surveyed a sample of forty-two students from the University of London in her work “The Extent 
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of Student Knowledge on the Current UK Drugs Policy, and their Perception of Harms in Illegal 
Drugs.” Replication studies are useful not only in establishing consistent research findings 
through the use of different population samples, but also in examining the findings of different 
countries—such as that of the United Kingdom and the United States, which this research 
accomplishes. For these reasons, this study was performed almost identically to that of Higson’s 
study performed in the UK, adhering to the idea that “a basic requirement for scientific integrity 
is the ability to replicate the results of research” (Burman, Reed, & Alm, 2010, p. 787).  
In accordance with replication study research, the questionnaire used in this study 
(Appendix 2) was similar to that used in the original study. The researcher for this study gained 
permission from original researcher Higson to replicate a similar research in the United States 
using Higson’s questionnaire as a template. Changes were made to the original questionnaire 
only in terms of some of the illicit drugs mentioned, punishment multiple choice options, and 
classification terminology. Because the original questionnaire was distributed among United 
Kingdom students, some of the drugs listed by Higson were not yet widely recognized or posing 
an issue to American students, in addition to punishment terms and classifications being different 
from that used in the United States. For these reasons, only minor changes such as these were 
made to the questionnaire used in this study, such as replacing unrecognized drug names to 
United States students with recognized drug names, United Kingdom punishment terms with 
United States punishment terms, and the wording of “class” to “schedule” with regards to drug 
classifications in the U.S. 
Research was conducted in an East Tennessee State University classroom setting and was 
not administered off the university grounds. Respondents were given a 28-question multiple 
choice questionnaire as the method of data collection and were instructed to read each question 
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themselves as well as answer each questions themselves. The questionnaires were handed out to 
students during classroom times for approximately 15 minutes’ duration. Participants were 
informed that the nature of the study is to find out how much knowledge and understanding that 
they have on the United States drug classifications, federal possession penalties, and harms 
resulting from illicit drug use. Each survey was answered and submitted by the sole completer of 
the questionnaire, ensuring both limited researcher influence and a heightened level of honesty 
among each participant. The questionnaire was largely comprised of questions concerning 
student knowledge on various drug topics, with various drugs’ “street names” being used in 
parenthesis beside the drug in question.  
Ethical Considerations 
Ethical considerations are a necessary element that ensures participant protection and 
honest research. Having a set of ethical guidelines in place can reduce harm or prevent it entirely 
(Eisenhauer & Wynaden, 2001, p. 93). Prior to conducting research, ethical concerns and 
participant involvement were carefully examined by the ETSU Institutional Review Board 
(IRB). To protect against unwilling or unknowledgeable participant involvement, an informed 
consent document (Appendix 1) was created and delivered both physically and verbally to 
participants prior to questionnaire distribution. Informed consent not only provides enough 
information about the research design so that a rational decision on whether or not to participate 
can be made, but also allows for voluntary involvement and the right to abandon the study at any 
given time (Gillespie, 1995, Minimizing Risk section, para. 5). In addition to voluntary 
involvement, participants’ names and contact information were not asked to be provided on the 
questionnaire so that the questionnaires remained entirely anonymous in order to protect the 
identity of the participant. In research, it is fundamental that every effort be exhausted to protect 
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participants’ privacy, as well as inform them of research goals, methodology, conflicts of 
interest, and potential risks involved in the research (World Medical Association, 2001, p. 374). 
Medical or psychological resources were not required due to the nature of this research 
being a test of student knowledge on the U.S. drug policy and the potential harms of drug abuse. 
The questionnaire did not ask if participants had ever used drugs or knew of someone who used 
drugs. Participants were provided an informational sheet (Appendix 1) to keep with links to 
multiple resources regarding answers to the content covered in the questionnaire, as well as the 
researcher’s contact information and a summary of the research project being performed.  
Chapter 3: Results 
This section is dedicated to examining the research findings obtained from the student 
surveys, which served as the primary research for this study. A total of 40 surveys was collected 
from respondents at East Tennessee State University who fell in the age range of 18-25 years 
old. Of the respondents, 58% were male and 42% were female. The survey responses to be 
studied in this chapter pertain to the appropriate class of nine different drugs, the federal 
minimum and maximum penalties resultant from being convicted of illegal possession, and 
finally the level of harmfulness that respondents believed were associated with these specific 
drugs.  
Drug Classifications 
Respondents were first asked to which class/schedule a certain drug belonged. The 
question was asked a total of nine times throughout the survey, with a different drug name being 
asked each time. Respondents were given multiple choice options which included Schedule I, 
Schedule II, Schedule III, Schedule IV, Schedule V, and Legal.  
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FIGURE 1 – Respondents answers to drug classifications; percentages taken from questions 1, 
4, 7, 10, 13, 16, 19, 22 and 25. 
 
Figure 1 reveals almost half of the respondents (47.5%) chose the correct drug 
classification for Cannabis and Ketamine. Approximately one-third (30%) of respondents 
incorrectly categorized Ecstasy and LSD as a Schedule III drug—which would indicate some 
instances of accepted medical use and less-drug dependency—instead of its correct 
categorization as a Schedule I drug. Interestingly, another 30% of respondents categorized 
Inhalants as a Schedule III drug instead of Legal, which would be the correct answer as Inhalants 
are currently not classified under the Controlled Substances Act. Less than one-fifth (17.5%) of 
 
Schedule 
I 
Schedule 
II 
Schedule 
III 
Schedule 
IV 
Schedule 
V 
Legal 
Correct 
Answer 
1. Cannabis 47.5% 17.5% 17.5% 7.5% 10%  Schedule I 
2. Ecstasy 22.5% 25% 30% 15% 7.5%  Schedule I 
3. Ketamine 7.5% 20% 47.5% 12.5% 12.5%  
Schedule 
III 
4. Cocaine 25% 17.5% 12.5% 20% 25%  Schedule II 
5. Mushrooms 17.5% 22.5% 25% 20% 15%  Schedule I 
6. Heroin 25% 12.5% 5% 20% 37.5%  Schedule I 
7. 
Amphetamine 
27.5% 20% 12.5% 20% 17.5% 2.5% Schedule II 
8. Inhalants 22.5% 12.5% 30% 25% 7.5% 2.5% Legal 
9. LSD 25% 12.5% 30% 12.5% 20%  Schedule I 
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respondents correctly chose Cocaine as being a Schedule II drug due to its high level of drug 
dependency, while another 25% each chose Schedule I and Schedule V. A similar response was 
seen for Heroin, where only one-fourth (25%) of respondents correctly labeled Heroin as a 
Schedule I drug, while over one-third (37.5%) of respondents incorrectly chose Schedule V as 
the appropriate classification. The classification for Mushrooms was split almost evenly among 
the Schedule classifications, revealing an obvious knowledge deficiency as only 17.5% of 
respondents chose the correct answer for this Schedule I drug. Amphetamine was chosen by 
most respondents (27.5%) to be a Schedule I drug, while 20% correctly chose Schedule II as its 
classification.  
Federal Sentencing 
FIGURE 2 – Respondents answers to federal minimum sentencing on simple possession 
charges; percentages taken from questions 2, 5, 8, 11, 14, 17, 20, 23 and 26.  
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In the series of survey questions regarding federal sentencing, respondents were asked 
what they considered to be the minimum federal punishment for being caught in simple 
possession of each of the nine different drugs mentioned. Respondents were given choices that 
ranged from “No federal punishment” to “Prison and a $5,000 fine.” The correct answer for all 
of the nine mentioned drugs, excluding Inhalants which are currently legal and therefore have no 
federal punishment, was “Prison and a $1,000 fine” (21 U.S.C. § 844). 
According to Figure 2, which captures the respondents’ answers these questions, all of 
the categories had an incorrect majority response. Inhalants, being the only legal drug mentioned, 
represented the largest category (90%) of incorrect responses, with only 10% of respondents 
choosing the correct answer of “No federal punishment.” An overwhelming majority (82.5%) 
gave incorrect responses for minimum federal sentencing of Ketamine and Heroin possession. 
Other categories that reflect a high incorrect response rate include Mushrooms (80%), Cannabis 
(75%), LSD (70%), Amphetamine (67.5%), and Cocaine (62.5%). Ecstasy was almost split in 
terms of correct and incorrect responses, with incorrect responses still ranking slightly higher 
(52.5%). 
With regards to the incorrect responses, which included “No federal punishment” as one 
of the multiple-choice options, it is interesting to note that a small percentage of respondents 
incorrectly labeled some of the above-listed illicit drugs as not having a federal minimum 
punishment associated with simple possession charges. The highest percentage represented was 
Cannabis (15%), which respondents believed there to be no federal minimum punishment in 
existence. Following in incorrect responses was Amphetamine (7.5%), Ketamine (5%), Ecstasy 
(2.5%) and Mushrooms (2.5%).  
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FIGURE 3 – Respondents answers to federal maximum sentencing on simple possession 
charges; percentages taken from questions 3, 6, 9, 12, 15, 18, 21, 24 and 27.  
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while in Figure 2 respondents had the highest correct response percentages in these two 
categories. Closely resembling Figure 2, Figure 3 reveals that (82.5%) of respondents gave 
incorrect responses for maximum federal sentencing of Ketamine, Heroin, Amphetamine, and 
LSD possession. Categories following in high incorrect response rate include Cannabis (77.5%) 
and Mushrooms (62.5%). 
With regards to the incorrect responses, which included “No federal punishment” as a 
multiple-choice option, a small number of respondents incorrectly identified some of the above-
listed illicit drugs as having no federal maximum punishment associated with simple possession 
charges at the 3rd offense level. The highest percentage of incorrect responses was Ecstasy 
(7.5%), in which circumstance respondents believed that no federal maximum punishment would 
be given. Following in incorrect responses was Cannabis (5%), Ketamine (5%), Amphetamine 
(2.5%) and Mushrooms (2.5%).   
FIGURE 4 – Respondents answers to perceived harms; percentages from question 28. 
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Respondents were asked to rank each of the nine drugs by their perceived level of 
harmfulness, with one representing the least level of harm and five representing the greatest level 
of harm. Figure 4 reveals that the overwhelming majority of respondents (92.5%) believed that 
Heroin caused the highest level of harm. Following next in highest level of harm rankings was 
Amphetamine (55%), Cocaine (45%), and LSD (45%). Perceived to be the least harmful was 
Cannabis (60%), with only 2.5% ranking it as having the highest level of harm. Over half of the 
respondents believed Ecstasy (57.5%) and Ketamine (52.5%) to be a Level 3 harm, while 
Inhalants (40%) were believed to be a Level 4 harm. Mushrooms was labeled by 35% of 
respondents as a Level 2 harmful drug. Respondents for the categories of Ketamine, Cocaine, 
Heroin, Amphetamine, and LSD left Level 1 blank. The next chapter will discuss the 
implications of these survey findings. 
Chapter 4: Findings Discussion 
The findings from the responses given in the previous chapter will be discussed in this 
chapter as well as evaluated with prior research on the topic. Topics researched in this chapter 
will include the classifications of the nine studied drugs as well as the perceived harmfulness of 
these drugs. With regards to these findings, the subject of U.S. drug classifications will be 
discussed as such classifications are categorized according to how harmful a drug is in terms of 
abuse potential and severe dependency issues. Additionally, this chapter will examine 
respondents’ answers in the categories of federal sentencing guidelines and perceived 
harmfulness in an effort to find any correlation, or lack thereof, between the level of knowledge 
of these two issues. Finally, the implications of such findings will be discussed. A knowledge 
deficiency as evidenced in the responses could indicate a greater need for United States drug 
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policies and drug abuse harms to be taught more prevalently in classrooms or other areas of 
education, as previous research has shown, which will also be noted in this chapter.  
Drug Classifications 
In the questionnaire, participants were asked to classify each of the nine different drugs used 
in this study. The multiple choice options given were Schedule I, Schedule II, Schedule III, Schedule 
IV, Schedule V, and Legal. The results from these nine questions revealed a clear lack of knowledge 
for a majority of the drugs studied. Cannabis was correctly classified as a Schedule I drug by only 
47.5% of respondents, as was Ketamine as a Schedule III drug. With the more recent media attention 
on Cannabis and its legalized status and medically-accepted usage in some states, knowing how to 
classify the drug on a federal level may have proved difficult for some students, accounting for under 
half of the surveyed population choosing the correct categorization. Furthermore, considering these 
state stances on accepted Cannabis use, it may be seem bizarre for participants to think of placing 
Cannabis “in a graver category than cocaine and on a par with heroin” (Blumenson & Nilsen, 
2009, p. 2). Such a finding on split student responses could very well illustrate confusion over 
differing state and federal laws, as well as a variety of differing medical marijuana legislation 
that is continually evolving (Pacula, Chriqui, Reichmann & Terry-McElrath, 2002, p. 1). As 
some state laws allow for medicinal use of cannabis, these laws could very well be creating a 
new mindset that cannabis is a less wicked or dangerous drug and more socially-accepted than 
federal laws would have the population believe (Mikos, 2009, p. 1424). 
One-fourth (25%) of respondents correctly identified Heroin and LSD and a Schedule I 
drug. Interestingly for Heroin, more respondents (37.5%) chose Schedule V as their answer. A 
possible reasoning for this majority error could be that participants incorrectly assumed that 
Schedule V referred to the classification of drugs belonging to the Schedule I category, where 
drugs have a high abuse potential and no appropriate medicinal use in the United States (21 
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U.S.C. § 812). The alternative reasoning, on the other hand, would be that participants believed 
Heroin to actually fall into the Schedule V classification. Such a rationale seems difficult to 
believe, however, as Heroin has been labeled by some as the “worst drug in the world” and one 
that is believed by many to lead to “intractable, lifelong addiction” (Robins, Compton, & Horton, 
2000, p. 530). Nevertheless, the data clearly reveals that with regards to Heroin, a majority of 
participants either lacked in knowledge of the Federal Drug Scheduling chart, the abuse potential 
and lack of accepted medical use of the drug, or both. LSD was almost evenly split in majority 
responses as being a Schedule I drug (25%), Schedule III drug (30%) or Schedule V drug (20%). 
As previously stated, the correct classification for LSD is a Schedule I drug. Similar to the 
uncertainty of the answers pertaining to Heroin, participants appear to have less knowledge 
regarding how LSD is classified federally, with answers belonging in both extreme categories as 
well as in the middle. Again, a potential reasoning for such responses could be due to students’ 
inability to correctly identify how abuse potential and approved medical uses were ranked in the 
Federal Drug Scheduling chart, such as if a student incorrectly believed Schedule V to represent 
the Schedule I category. Another possible reason would be that LSD was considered to be a 
moderate or acceptable drug, depending on participants who placed LSD into Schedule III or 
Schedule V. In examining the level of perceived safety among certain drugs, LSD has been 
ranked in the same category of alcohol and prescriptions as being relatively safe, while higher 
risk was designated to drugs such as heroin and cocaine (Gamma, Jerome, Liechti, & Sumnall, 
2005, p. 188). In reality, however, LSD falls into the same federal classification of Heroin as a 
Schedule I drug. From these findings, it can be assumed that the knowledge surrounding LSD is 
either lacking with regard to the federal scheduling of this drug or with regard to its high abuse 
potential.  
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Approximately one-fifth of respondents gave the correct answer for Ecstasy (22.5%), 
Amphetamine (20%), Cocaine (17.5%), and Mushrooms (17.5%). Ecstasy and Mushrooms, both 
being Schedule I drugs, were selected by the majority of respondents in both cases to be a 
Schedule III drug. Such results indicate that more respondents assumed Ecstasy and Mushrooms 
to be less dangerous and not as addicting as these drugs actually are. In light of recent research 
which states that ecstasy is often thought of as a harmless recreational drug choice (Williams, 
Meagher, & Galligan, 1993, p. 44), it can be assumed that respondents answered this way out of 
the belief that such drugs are merely recreational and therefore less-harmful. For cocaine, a 
majority of respondents incorrectly placed cocaine as a Schedule I drug (25%) or a Schedule V 
drug (25%), when the correct response was a Schedule II drug. With 25% of respondents placing 
Cocaine as a Schedule V drug, it may be assumed that these participants incorrectly believed the 
arrangement of the Federal Drug Scheduling chart to be reversed (with Schedule I harms 
belonging to the category of Schedule V, and vice versa), as opposed to this drug actually 
belonging to the Schedule V category where the abuse potential is much lower and the potential 
for medical usage exists (21 U.S.C. § 812). However, in light of the fact that addiction caused by 
cocaine is widely recognized as harmful (Goodger, Wang, & Pogrel, 2005, p. 333), it is also true 
that cocaine’s widespread abuse stems from its “reputation as a relatively safe recreational drug” 
(Washton & Tatarsky, 1984, p. 252). Knowing this, it becomes difficult to determine if Cocaine 
was believed by one-fourth of respondents to actually be a non-dangerous drug or if respondents 
lacked correct knowledge of the Federal classifications. In the case of Amphetamine, more 
respondents (27.5%) chose Schedule I to be the correct classification, while the correct answer 
was Schedule II. Interestingly, 2.5% of respondents believed Amphetamines to be legal on the 
federal level. Evidently, a lack of awareness of the harms and abuse likelihood is not as well-
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known as it should be, as less than half (47.5%) of respondents placed Amphetamines into the 
higher scheduling classifications.  
Sentencing and Harms 
Next in the survey, participants were questioned in their knowledge of federal minimum 
and maximum sentencing guidelines with regard to possession charges of the drugs listed in this 
study. Incorrect responses were far more common than correct responses, as seen in Figures 2 
and 3 from the previous chapter. The drug with the highest incorrect response rate in both 
categories of minimum and maximum sentencing was Inhalants. Because Inhalants were the only 
legal drug listed in the survey, it is likely that participants were unaware of its federally-legalized 
status and therefore chose an answer related to punishment. With regards to the minimum 
sentencing responses, the highest correct response rate (47.5%) was Ecstasy, while the highest 
correct response rate (37.5%) in the maximum sentencing responses was Mushrooms. 
Nevertheless, correct responses in these two categories are represented by less than half of 
respondents’ answers. In terms of average correct responses, minimum sentencing responses had 
an average correct response of 26.4% while maximum sentencing responses had an average 
correct response of 17.8%. From these findings, it can be presumed that federal sentencing 
standards are not well-known, at least in the case of the student population observed in this 
study. Such results may point to a lack of education regarding federal drug sentencing guidelines, 
either due to institutions’ failure to teach on the subject or lack of informing oneself on federal 
law.  
The legal consequences of drug abuse is important to young people because it can 
negatively influence their social status (Hemmelstein, 1995). Therefore, it is understood that a 
personal motivation to inform oneself of the potential federal consequences that result from drug 
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possession should at least influence some level of knowledge regarding the subject. Conversely, 
this may only be true of actual drug users themselves, as the risk of federal punishment might not 
be as substantial to non-user populations. Before discussing the findings of the sentencing 
questions further, it is important to note how respondents classified these drugs in terms of 
perceived harm. Such findings offer better insight into the correlation between believed harms 
and risk of punishment. 
The last section of the survey asked participants to identify they believed these drugs 
ranked in terms of least harmful to most harmful. The most frequently observed high-risk drug 
(Level 5) in Figure 4 was Heroin (92.5%), followed by Amphetamine (55%), Cocaine (45%), 
and LSD (45%). Only Inhalants were chose by a majority of respondents (40%) to belong to the 
next-highest harm category (Level 4). Drugs ranking highest in the moderate-risk category 
(Level 3) were Ecstasy (57.5%) and Ketamine (52.5%). The only drug considered to be a 
relatively-low harm (Level 2) by the majority of respondents was Mushrooms (35%), while 
Cannabis was the only drug to reach majority response (60%) in the lowest-harm category (Level 
1).  
While illicit drugs obviously carry some form of harm, not all of these drugs carry the 
same stigmatizations (Ahern, Stuber, & Galea, 2007, p. 188). Some of these drugs which carry 
the higher stigmas are heroin, cocaine, and hallucinogens such as LSD (Harrel, Kapsak, Cisin, & 
Wirtz, 1997, p. 49). Such stigmatizations may lead the general public to believe that these drugs 
carry a greater risk of harm, whether or not these individuals have experienced the harms of 
these drugs personally. Cannabis, on the other hand, which was perceived to be in the lowest-
harm drug category, was first legalized for medical purposes in 1996 (Cerdá, Wall, Keyes, 
Galea, & Hasin, 2012, p. 23) and has now reached medical legalization status in 23 states and the 
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District of Columbia. State laws such as these can foster the acceptability of marijuana use in 
society and minimize the drug’s perceived harms (Lynne-Landsman, Livingston, & Wagenaar, 
2013, p. 1500). Such recent changes to legislation concerning Cannabis, therefore, causes the 
stigmatization for Cannabis to be much lower, despite the fact that many studies still point to the 
belief that Cannabis is a gateway drug to other illicit drugs (Hall & Lynskey, 2005, p. 41). For 
these reasons, stigmatization itself can be a type of knowledge base for non-drug users to 
reference when confronted with ranking the levels of harm of certain drugs, as performed in this 
study. Without further research into the matter, it cannot be stated conclusively whether 
participants in this study based their answers off of personal knowledge—either through 
themselves or someone they knew—or if answers were based off of certain stigmatizations, and 
lack thereof, of certain drugs.  
While a drug’s level of harm in terms of severe physical and psychological dependence 
certainly influences how a certain type of drug is classified under the Federal Drug Scheduling 
chart, harmfulness is not the only factor. It is important to note that a variety of charts exist 
which attempt to rate drugs in terms of their harmfulness, with Heroin most often listed as the 
most harmful drug. While charts such as these are certainly useful in studying the categorical 
harmfulness of drugs, often these charts factor in ‘harm to oneself’ and ‘harm to others’ together 
to create a ranking. To combine these two separate types of harms, however, regularly leads to a 
flawed analysis (Caulkins, Reuter, & Coulson, 2011, p. 1886). Nevertheless, this idea of 
classifying drugs in rank-order based on their possibility of harm is important, because “such 
rankings could form the basis of differential control policies, reflecting…the relative magnitudes 
of the problems posed by different types of drugs” (Kalant, 1999, p. 26). Such calculations of 
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drug risks could help both to influence drug-related policies and to further public education on 
the issue, thereby decreasing future harms caused by drugs (Rolles & Measham, 2011, p. 243). 
Taking into consideration this present study’s responses to harms, a reexamination of 
participants’ responses to sentencing reveals some correlating trends. As research suggests, 
stigmatization towards certain drugs can more easily occur when one’s behavior and physical 
appearance worsens as a result of drug use, as opposed to those who use so-called ‘recreational’ 
drugs (Parker, Williams, & Aldridge, 2002, p. 943). Not surprisingly, the drugs which were 
viewed as causing the highest level of harm in this study were also presumed to have the highest 
federal punishments, while drugs which were viewed as having the lowest level of harm were 
presumed to have either no federal punishment or the lowest level of punishment. Heroin, which 
ranked highest in harmfulness, was presumed by 65% of respondents as having the highest 
maximum punishment (10 years and a fine). A similar outcome was seen with the drugs Cocaine 
and LSD, both of which ranked high in level of harm and were believed by the majority of 
respondents (52.5% and 42.5% respectively) to receive the highest maximum punishment. 
Interestingly, as already discussed in the previous chapter, the correct answer for each of the 
illicit drugs mentioned with regards to federal maximum penalties is 3 years in prison and a fine, 
although multiple choice options ranged from “no federal punishment” to “10 years and a fine.” 
On the contrary, Cannabis, which ranked lowest in harmfulness, was believed by 62.5% of 
respondents to carry either no federal punishment or the lowest possible sentence ($1,000 fine). 
Likewise, Mushrooms carried the next-lowest perception of harm and similarly was chosen to 
50% of respondents to carry no federal punishment or the lowest possible sentence. The correct 
answer for minimum federal charges regarding these illicit drugs is “prison and $1,000 fine.” 
From these responses, a correlation can be observed between participants’ perception of harm 
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and potential federal punishment charges. Drugs believed to be most harmful were given stricter 
sentencing, while drugs believed to be least harmful were given the more lenient sentences (see 
Figure 2, 3, and 4).  
Chapter 5: Conclusion 
Findings from the previous chapter points to the need for increased public education 
concerning drug laws and harms. More specifically, with the university-age population 
representing the highest percentage of illicit drug users, it could be theorized that a greater 
opportunity exists for improved drug education at the university level. Although recently there 
have been increased federal policies and strong funding through the US Department of Education 
to enhance the effectiveness of substance prevention strategies (Hallfors & Godette, 2002, p. 
461), widespread-promoted curricula is still largely being used by schools despite these program 
materials either being inadequately evaluated or being found unsuccessful in terms of actually 
decreasing drug abuse (Rohrbach et al., 1996; Tobler & Stratton, 1997; Swisher, 2000). 
Primarily, this is caused by the false assumption that because a program is widely-accepted, it 
must also be deemed effective. However, the ineffectiveness of these and other popular drug 
education programs such as D.A.R.E validates the need to “return to the drawing board” in order 
to reevaluate current policies and trends regarding substance abuse prevention (Rosenbaum & 
Hanson, 1998). 
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APPENDIX 1 
Informed Consent 
 
Title: Measuring the Level of University Student Knowledge on the U.S. Drug Policy and Harms 
Associated with Illicit Drug Use: A Replication Study 
 
East Tennessee State University 
 
My name is Ashley Williams. I am a senior conducting questionnaires for my 
undergraduate thesis research project. The aim of this research is to examine the 
understanding and knowledge that aged 18- 25 year old students have on the U.S. drugs 
policy.   
You are being asked to complete this voluntary questionnaire, lasting approximately 5-10 
minutes. There will be a series of questions asking the possible sentences for drug 
possession and your view on harmful drugs. This questionnaire is completely anonymous; 
it will not ask you for your name, address, or email address. You will not be asked about 
any personal drug use. You have the right to withdraw at any time without having to give 
reason.  
Thank you for taking the time and agreeing to complete this questionnaire. By completing 
this questionnaire you are confirming your consent to take part in this study. 
 
The aims of the research are to:  
1. Measure participants’ factual knowledge of the U.S. drugs policy.  
2. Measure which drugs participants think are the most harmful to the user.  
3. Measure the participants understanding of criminal procedures associated with drug possession in the 
U.S.  
4. Assess the extent to which 18-25 year olds understand U.S. drug policy.  
 
Note: 
 You must be at least 18 years old and no older than 25 to take part in this survey. 
 This survey will be used as research 
 Taking part in this survey is voluntary 
 If you choose to take part in this study, you will be asked to complete this survey to be 
used in research involving student knowledge on the U.S. drug policy and harms 
associated with using illicit drugs. 
 Your survey responses will remain anonymous and no identifying personal factors will be 
used. 
 You do not have to answer any question that makes you feel uncomfortable or relates to 
matters that you do not wish to talk about.  
 You have the right to withdraw from the interview at any time without disadvantage to 
yourself and without being obliged to give any reason. If you find you would like to 
withdraw from the study after the questionnaire has been completed, please notify the 
Primary Investigator prior to turning in your survey and your survey will not be included 
in the research and discarded.  
 By choosing to take part in this survey, you consent for your answers to be used 
anonymously in this research. 
 Contact info for the Primary Investigator:  
o Phone: (423) 291-2780 
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o Email: williamsae2@goldmail.etsu.edu 
 
Links to additional information: 
Federal Drug Penalties: http://www.bu.edu/safety/alcohol-drugs/laws/  
Federal Drug Schedule Classifications http://www.drugabuse.gov/drugs-abuse/commonly-
abused-drugs-charts/commonly-abused-drugs-chart  
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APPENDIX 2 
 
 
 
1. What class/schedule is cannabis (‘weed’, ‘pot’)? 
a) Schedule I 
b) Schedule II 
c) Schedule III 
d) Schedule IV 
e) Schedule V 
f) Legal 
 
2. What is the federal minimum penalty for being caught in simple possession (1st offense) of 
cannabis?  
a) $1,000 fine 
b) Prison and $5,000 fine 
c) Prison and $1,000 fine 
d) $5,000 fine 
e)   No federal punishment 
 
3. What is the federal maximum penalty for being caught in simple possession (3rd offense, no 
aggravating circumstances) of cannabis?  
a) 5 years prison and fine 
b) 10 years prison and fine  
c) 1 years prison and fine  
d) 3 years prison and fine 
e)   No federal punishment 
            
4. What class/schedule is ecstasy (‘MDMA’)?  
a)   Schedule I 
b)   Schedule II 
c)   Schedule III 
d)   Schedule IV 
e)   Schedule V 
f)   Legal 
 
Please answer all of the following questions:    
  
Your details:   
                                           Gender:                         Age:                    Female.       Male   
Where are you originally from? :   
What course are you studying?  :   
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 5. 2. What is the federal minimum penalty for being caught in simple possession (1st offense) of 
ecstasy?  
a)   Prison and $5,000 fine 
b)   $1,000 fine  
c)   Prison and $1,000 fine 
d)   $5,000 fine 
e)   No federal punishment 
 
6. What is the federal maximum penalty for being caught in simple possession (3rd offense, no 
aggravating circumstances) of ecstasy?  
a)   3 years prison and fine  
  b)   5 years prison and fine  
  c)   1 year prison and fine  
d)   10 years prison  
e)   No federal punishment 
  
7. What class is Ketamine (‘K’, ‘kit-kat’)?  
a)   Schedule I 
b)   Schedule II 
c)   Schedule III 
d)   Schedule IV 
e)   Schedule V 
 f)    Legal  
  
8. 2. What is the federal minimum penalty for being caught in simple possession (1st offense) 
of Ketamine?           
a)   Prison and $5,000 fine  
  b)   $5,000 fine 
c)   $1,000 fine      
d)   Prison and $1,000 fine    
e)   No federal punishment                               
 
9. What is the federal maximum penalty for being caught in simple possession (3rd offense, no 
aggravating circumstances) of Ketamine?  
        a)   1 year prison and fine  
  b)   10 years prison and fine  
  c)   3 years prison and fine 
  d)   5 years prison and fine  
 e)   No federal punishment 
 
10.   What class is Cocaine (‘candy’, ‘powder’)?  
a)   Schedule I 
b)   Schedule II 
c)   Schedule III 
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d)   Schedule IV 
e)   Schedule V 
f)   Legal 
   
11.   2. What is the federal minimum penalty for being caught in simple possession (1st offense) of 
Cocaine?  
           a)   Prison and $5,000 fine  
b)   Prison and $1,000 fine  
c)   $1,000 fine   
d)   $5,000 fine 
e)   No federal punishment 
  
12.   What is the federal maximum penalty for being caught in simple possession (3rd offense, no 
aggravating circumstances) of Cocaine?  
           a)   3 years prison and fine  
b)   5 years prison and fine  
c)    1 years prison and fine  
  d)   10 years prison and fine  
 e)   No federal punishment 
  
13.   What class are Mushrooms (‘shrooms’, ‘magic mushrooms’)?  
  a)   Schedule I 
b)   Schedule II 
c)   Schedule III 
d)   Schedule IV 
e)   Schedule V 
f)   Legal 
  
14.   2. What is the federal minimum penalty for being caught in simple possession (1st offense) of 
Mushrooms?  
          a)   Prison and $5,000 fine 
  b)   $1,000 fine  
  c)   Prison and $1,000 fine 
 d)   $5,000 fine 
 e)   No federal punishment 
 
15. What is the federal maximum penalty for being caught in simple possession (3rd offense, no 
aggravating circumstances) of Mushrooms?  
   a)   5 years prison and fine  
  b)   3 years prison and fine  
  c)   10 years prison and fine  
d)   1 year prison and fine  
e)   No federal punishment 
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16.   What class is heroin (‘dope’, ‘smack’)?  
a)   Schedule I 
b)   Schedule II 
c)   Schedule III 
d)   Schedule IV 
e)   Schedule V 
f)   Legal 
  
 17.   2. What is the federal minimum penalty for being caught in simple possession (1st offense) of 
heroin?  
            a)   $1,000 fine  
b)   Prison and $5,000 fine  
c)   $5,000 fine 
d)   Prison and $1,000 fine 
e)   No federal punishment  
 
18.   What is the federal maximum penalty for being caught in simple possession (3rd offense, no 
aggravating circumstances) of heroin?  
           a)   3 years prison and fine 
 b)   10 years prison and fine  
c)   1 year prison and fine  
  d)   5 years prison and fine  
 e)   No federal punishment 
 
19.   What class is Amphetamine (‘speed’, ‘uppers’)?  
a)   Schedule I 
b)   Schedule II 
c)   Schedule III 
d)   Schedule IV 
e)   Schedule V 
f)   Legal 
  
20.   2. What is the federal minimum penalty for being caught in simple possession (1st offense) of 
Amphetamine?  
a)   Prison and $5,000 fine 
b)   Prison and $1,000 fine  
  c)   $1,000 fine  
 d)   $5,000 fine  
 e)   No federal punishment 
  
21.   What is the federal maximum penalty for being caught in simple possession (3rd offense, no 
aggravating circumstances) of Amphetamine?  
            a)   10 years prison and fine  
  b)   5 years prison and fine  
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c)   1 year prison and fine  
d)   3 years prison and fine  
e)   No federal punishment 
 
22.   What class/schedule is Inhalants (‘poppers’, ‘snappers’)? 
a)   Schedule I 
b)   Schedule II 
c)   Schedule III 
d)   Schedule IV 
e)   Schedule V 
f)   Legal 
 
23.   2. What is the federal minimum penalty for being caught in simple possession (1st offense) of 
Inhalants?  
a)   $1,000 fine 
b)   Prison and $5,000 fine 
c)   Prison and $1,000 fine 
d)   $5,000 fine 
e)   No federal punishment 
 
24.   What is the federal maximum penalty for being caught in simple possession (3rd offense, no 
aggravating circumstances) of Inhalants?  
a)   5 years prison and fine 
b)   10 years prison and fine  
c)   1 years prison and fine  
d)   3 years prison and fine 
e)   No federal punishment 
 
25.   What class/schedule is LSD (‘acid’)? 
a)   Schedule I 
b)   Schedule II 
c)   Schedule III 
d)   Schedule IV 
e)   Schedule V 
f)   Legal 
 
26.   2. What is the federal minimum penalty for being caught in simple possession (1st offense) of LSD?  
a)   $5,000 fine 
b)   Prison and $1,000 fine 
c)   Prison and $5,000 fine 
d)   $1,000 fine 
e)   No federal punishment 
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27.   What is the federal maximum penalty for being caught in simple possession (3rd offense, no 
aggravating circumstances) of LSD?  
a)   1 year prison and fine 
b)   10 years prison and fine  
c)   5 years prison and fine  
d)   3 years prison and fine 
e)   No federal punishment 
  
28.   What drug do you think is the most ‘harmful’ (physically, psychologically, and socially harms) to a 
person?  
(Please circle the number which you think suits best; 1 being the least harmful and 5 being the 
most harmful)  
 
a)   Cannabis               1     2      3     4     5     
  
b)   Ecstasy                 1     2     3      4     5  
  
c)   Ketamine               1     2     3      4     5  
  
d)   Cocaine                 1     2     3      4     5  
  
e)   Mushrooms           1     2     3     4     5         
  
f)   Heroin                   1     2      3     4     5  
  
g)   Amphetamine       1     2      3     4     5 
 
h)   Inhalants          1     2      3     4     5 
 
i)   LSD                      1     2      3     4     5 
 
 
If you could not answer any of the questions or have any feedback on this questionnaire, please feel free 
to write below. 
______________________________________________________________________________ 
______________________________________________________________________________ 
______________________________________________________________________________ 
______________________________________________________________________________ 
 
 
 
Federal Drug Penalties: http://www.bu.edu/safety/alcohol-drugs/laws/  
Federal Drug Schedule Classifications http://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs-
charts/commonly-abused-drugs-chart 
